Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Dalsspira Mejeri SPIRA Mar 3, 2021 3.47 +1.46   
 DanCann Pharma DANCAN Mar 3, 2021 3.33 +4.88   
 DDM Holding DDM Mar 3, 2021 29.60 +8.82   
 Dedicare B DEDI Mar 3, 2021 50.00 -1.96   
 Desenio Group AB DSNO Mar 3, 2021 87.50 0.00   
 DevPort DEVPB Mar 3, 2021 20.40 -1.92   
 DexTech Medical DEX Mar 3, 2021 49.70 +2.90   
 Diadrom Holding DIAH Mar 3, 2021 10.00 +0.20   
 Diamyd Medical B DMYDB Mar 3, 2021 36.00 -2.97   
 Dicot DICOT Mar 3, 2021 1.24 +2.90   
 Dignitana DIGN Mar 3, 2021 8.50 +8.42   
 DistIT DIST Mar 3, 2021 70.20 +0.29   
 Dividend Sweden B DIVIB Mar 3, 2021 1.30 +4.84   
 Divio Technologies B DIVIOB Mar 3, 2021 2.89 -3.67   
 Diös Fastigheter DIOS Mar 3, 2021 68.85 +0.73   
 DNB DNBO Mar 3, 2021 170.20 0.00   
 DNO DNOO Mar 3, 2021 8.19 -1.52   
 DOF DOFO Mar 3, 2021 0.76 0.00   
 Dome Energy DOME Mar 3, 2021 2.06 +3.00   
 Dometic Group DOM Mar 3, 2021 119.55 +1.36   
 Doro DORO Mar 3, 2021 57.60 +0.35   
 Double Bond Pharmaceutical B DBPB Mar 3, 2021 2.00 0.00   
 Doxa DOXA Mar 3, 2021 2.16 +0.47   
 Drillcon DRIL Mar 3, 2021 8.50 -1.39   
 Duni DUNI Mar 3, 2021 104.80 -0.19   
 Duroc B DURCB Mar 3, 2021 26.40 -1.86   
 Dustin Group DUST Mar 3, 2021 86.50 +0.93   
 Eastnine EAST Mar 3, 2021 129.60 +1.73   
 EasyFill B EASYB Mar 3, 2021 2.20 -2.22   
 EatGood EATG Mar 3, 2021 2.00 -16.67   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK